Genomic Diversity of HPV6 and HPV11 in Recurrent Respiratory Papillomatosis: Association with Malignant Transformation in the Lungs and Clinical Outcomes.

Autor: Rahmoun M; Laboratory MIVEGEC (Univ Montpellier, CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France., Aussel A; Service d'anatomie et cytologie pathologiques, CHU de Montpellier, Montpellier, France., Bouzidi S; Laboratory MIVEGEC (Univ Montpellier, CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France., Pedergnana V; Laboratory MIVEGEC (Univ Montpellier, CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France., Malassigné V; Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France., Puech J; Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Veyer D; Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France; Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Péré H; Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France; Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Lepine C; Nantes University, CHU de Nantes, Pathology Department, Nantes, France; INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, Nantes, France., Blanc F; Department of Head and Neck Surgery, CHU de Montpellier, Montpellier, France., Boulle N; Pathogenesis and Control of Chronic and Emerging Infections, Department of Pathology and Oncobiology, Laboratory of Solid Tumors, CHU Montpellier, University of Montpellier, INSERM, EFS, Montpellier, France., Costes-Martineau V; Service d'anatomie et cytologie pathologiques, CHU de Montpellier, Montpellier, France., Bravo IG; Laboratory MIVEGEC (Univ Montpellier, CNRS, IRD), French National Center for Scientific Research (CNRS), Montpellier, France. Electronic address: ignacio.bravo@cnrs.fr.

Publikováno v: Tumour virus research [Tumour Virus Res] 2024 Oct 29, pp. 200294. Date of Electronic Publication: 2024 Oct 29.

Mitochondrial Variation in Anopheles gambiae and Anopheles coluzzii: Phylogeographic Legacy and Mitonuclear Associations With Metabolic Resistance to Pathogens and Insecticides.

Autor: Amaya Romero JE; Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen 9747 AG, Netherlands.; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France., Chenal C; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.; Institut des Science de l'Évolution de Montpellier, University of Montpellier, CNRS, Montpellier, France., Ben Chehida Y; Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen 9747 AG, Netherlands.; Ecology and Evolutionary Biology, School of Biosciences, University of Sheffield, Sheffield S10 2TN, UK., Miles A; Wellcome Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Clarkson CS; Wellcome Sanger Institute, Hinxton, Cambridge CB10 1SA, UK., Pedergnana V; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France., Wertheim B; Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen 9747 AG, Netherlands., Fontaine MC; Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen 9747 AG, Netherlands.; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.

Publikováno v: Genome biology and evolution [Genome Biol Evol] 2024 Sep 03; Vol. 16 (9).

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus.

Autor: Sy A; MRC Clinical Trials Unit, University College London, London, United Kingdom., McCabe L; MRC Clinical Trials Unit, University College London, London, United Kingdom., Hudson E; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom., Ansari AM; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom., Pedergnana V; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom., Lin SK; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom., Santana S; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom., Fiorino M; Mortimer Market Centre, Central and NorthWest London NHS Foundation Trust, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom., Ala A; Clinical and Experimental Medicine, University of Surrey, Guilford, United Kingdom., Stone B; Infectious Diseases, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom., Smith M; Hepatology, Brighton and Sussex Medical School, Brighton, United Kingdom., Nelson M; HIV Medicine, Chelsea & Westminster NHS Trust, London, United Kingdom., Barclay ST; Gastroenterology, Glasgow Royal Infirmary, Glasgow, United Kingdom., McPherson S; Hepatology, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom., Ryder SD; Hepatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Collier J; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom., Barnes E; Peter Medawar Building for Pathogen Research, Oxford, United Kingdom.; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom., Walker AS; MRC Clinical Trials Unit, University College London, London, United Kingdom., Pett SL; MRC Clinical Trials Unit, University College London, London, United Kingdom.; Mortimer Market Centre, Central and NorthWest London NHS Foundation Trust, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom., Cooke G; Department of Infectious Disease, Imperial College London, London, United Kingdom.; NIHR Biomedical Research Centre, Imperial College NHS Trust, London, United Kingdom.

Publikováno v: PloS one [PLoS One] 2023 Jan 23; Vol. 18 (1), pp. e0280551. Date of Electronic Publication: 2023 Jan 23 (Print Publication: 2023).

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.

Autor: Innes H; School of Health and Life SciencesGlasgow Caledonian UniversityGlasgowUnited Kingdom.; Population and Lifespan SciencesSchool of MedicineUniversity of NottinghamNottinghamUnited Kingdom.; Public Health ScotlandGlasgowUnited Kingdom., Nischalke HD; Department of Internal Medicine IUniversity HospitalUniversity of BonnBonnGermany., Guha IN; National Institute for Health Research (NIHR), Nottingham Biomedical Research CentreNottingham University Hospitals National Health Service Trust and the University of NottinghamNottinghamUnited Kingdom., Weiss KH; Department of Gastroenterology and HepatologyUniversity Hospital HeidelbergHeidelbergGermany., Irving W; National Institute for Health Research (NIHR), Nottingham Biomedical Research CentreNottingham University Hospitals National Health Service Trust and the University of NottinghamNottinghamUnited Kingdom., Gotthardt D; Department of Internal Medicine IVMedical University of HeidelbergHeidelbergGermany., Barnes E; Peter Medawar Building for Pathogen ResearchNuffield Department of Medicine and the Oxford NIHR Biomedical Research CentreOxford UniversityOxfordUnited Kingdom., Fischer J; Division of HepatologyDepartment of Medicine IILaboratory for Clinical and Experimental HepatologyLeipzig University Medical CenterLeipzigGermany., Ansari MA; Peter Medawar Building for Pathogen ResearchNuffield Department of Medicine and the Oxford NIHR Biomedical Research CentreOxford UniversityOxfordUnited Kingdom., Rosendahl J; Medical Department 1University Hospital HalleMartin-Luther Universität Halle-WittenbergHalleGermany., Lin SK; Peter Medawar Building for Pathogen ResearchNuffield Department of Medicine and the Oxford NIHR Biomedical Research CentreOxford UniversityOxfordUnited Kingdom., Marot A; Division of Gastroenterology and HepatologyCentre Hospitalier Universitaire VaudoisUniversité de LausanneLausanneSwitzerland.; Department of Gastroenterology and HepatologyCentre Hospitalier UniversitaireUCLouvain NamurUniversité Catholique de LouvainYvoirBelgium., Pedergnana V; Laboratoire MIVEGECMontpellierFrance., Casper M; Department of Medicine IISaarland University Medical CenterSaarland UniversityHomburgGermany., Benselin J; National Institute for Health Research (NIHR), Nottingham Biomedical Research CentreNottingham University Hospitals National Health Service Trust and the University of NottinghamNottinghamUnited Kingdom., Lammert F; Department of Medicine IISaarland University Medical CenterSaarland UniversityHomburgGermany., McLauchlan J; Medical Research Council-University of Glasgow Centre for Virus ResearchGlasgowUnited Kingdom., Lutz PL; Department of Internal Medicine IUniversity HospitalUniversity of BonnBonnGermany., Hamill V; School of Health and Life SciencesGlasgow Caledonian UniversityGlasgowUnited Kingdom.; Public Health ScotlandGlasgowUnited Kingdom., Mueller S; Center for Alcohol ResearchUniversity of HeidelbergHeidelbergGermany.; Medical DepartmentSalem Medical CenterHeidelbergGermany., Morling JR; Population and Lifespan SciencesSchool of MedicineUniversity of NottinghamNottinghamUnited Kingdom.; National Institute for Health Research (NIHR), Nottingham Biomedical Research CentreNottingham University Hospitals National Health Service Trust and the University of NottinghamNottinghamUnited Kingdom., Semmler G; Department of Internal Medicine IIIDivision of Gastroenterology and HepatologyMedical University of ViennaViennaAustria.; Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University SalzburgOberndorfAustria., Eyer F; Department of Clinical ToxicologyKlinikum Rechts der IsarTechnical University of MunichMunichGermany., von Felden J; Department of MedicineUniversity Medical Center Hamburg-EppendorfHamburgGermany., Link A; Department of Gastroenterology, Hepatology, and Infectious DiseasesOtto-von-Guericke University HospitalMagdeburgGermany., Vogel A; Department of Gastroenterology, Hepatology, and EndocrinologyHannover Medical SchoolHannoverGermany., Marquardt JU; Department of Medicine IUniversity Hospital Schleswig Holstein-Campus LübeckLübeckGermany., Sulk S; Medical Department 1University Hospital DresdenTechnische Universität DresdenDresdenGermany., Trebicka J; Department of Internal Medicine IGoethe UniversityFrankfurtGermany.; European Foundation for Study of Chronic Liver FailureBarcelonaSpain., Valenti L; Precision Medicine-Department of Transfusion Medicine and HematologyFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly.; Department of Pathophysiology and TransplantationUniversità degli Studi di MilanoMilanItaly., Datz C; Department of Internal Medicine, General Hospital Oberndorf, Teaching Hospital of the Paracelsus Medical University SalzburgOberndorfAustria., Reiberger T; Department of Internal Medicine IIIDivision of Gastroenterology and HepatologyMedical University of ViennaViennaAustria., Schafmayer C; Department of General, Visceral, Vascular, and Transplant SurgeryRostock University Medical CenterRostockGermany., Berg T; Division of HepatologyDepartment of Medicine IILaboratory for Clinical and Experimental HepatologyLeipzig University Medical CenterLeipzigGermany., Deltenre P; Division of Gastroenterology and HepatologyCentre Hospitalier Universitaire VaudoisUniversité de LausanneLausanneSwitzerland.; Department of GastroenterologyHepatopancreatology, and Digestive OncologyUniversity Clinics of Brussels Hospital ErasmeBrusselsBelgium.; Department of Gastroenterology and HepatologyClinique St LucBougeBelgium., Hampe J; Medical Department 1University Hospital DresdenTechnische Universität DresdenDresdenGermany.; Center for Regenerative Therapies DresdenTechnische Universität DresdenDresdenGermany., Stickel F; Department of Gastroenterology and HepatologyUniversity Hospital of ZurichZurichSwitzerland., Buch S; Medical Department 1University Hospital DresdenTechnische Universität DresdenDresdenGermany.

Publikováno v: Hepatology communications [Hepatol Commun] 2022 May; Vol. 6 (5), pp. 1213-1226. Date of Electronic Publication: 2021 Dec 27.

Impact of interferon lambda 4 genotype on interferon-stimulated gene expression during direct-acting antiviral therapy for hepatitis C

Autor: Ramamurthy, N, Marchi, E, Ansari, MA, Pedergnana, V, Mclean, A, Hudson, E, Bowden, R, Spencer, CCA, Barnes, E, Klenerman, P

New directly acting antivirals (DAAs) provide very high cure rates in most patients infected by hepatitis C virus (HCV). However, some patient groups have been relatively harder to treat, including those with cirrhosis or infected with HCV genotype 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::f07a88bbb0d6183e9860c1439a1afdd2
http://hdl.handle.net/10044/1/65471